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Recognition of Gram-negative bacteria by toll-like receptor (TLR)4 induces MyD88 and
TRIF mediated responses. We have shown that TRIF-dependent responses play an
important role in intestinal defense against Gram-negative enteropathogens. In the
current study, we examined underlying mechanisms of how systemic TRIF activation
enhances intestinal immune defense against Gram-negative bacteria. First we confirmed
that the protective effect of poly I:C against enteric infection of mice with Yersinia
enterocolitica was dependent on TLR3-mediated TRIF signaling by using TLR3-deficient
mice. This protection was unique in TRIF-dependent TLR signaling because systemic
stimulation of mice with agonists for TLR2 (Pam3CSK4) or TLR5 (flagellin) did not reduce
mortality on Y. enterocolitica infection. Systemic administration of poly I:C mobilized
CD11c+, F4/80+, and Gr−1hi cells from lamina propria and activated NK cells in the
mesenteric lymph nodes (MLN) within 24 h. This innate immune cell rearrangement was
type I IFN dependent and mediated through upregulation of TLR4 followed by CCR7
expression in these innate immune cells found in the intestinal mucosa. Poly I:C induced
IFN-γ expression by NK cells in the MLN, which was mediated through type I IFNs
and IL-12p40 from antigen presenting cells and consequent activation of STAT1 and
STAT4 in NK cells. This formation of innate immunity significantly contributed to the
elimination of bacteria in the MLN. Our results demonstrated an innate immune network
in the intestine that can be established by systemic stimulation of TRIF, which provides
a strong host defense against Gram-negative pathogens. The mechanism underlying
TRIF-mediated protective immunity may be useful to develop novel therapies for enteric
bacterial infection.
Keywords: intestine, TIR-domain-containing adapter-inducing interferon-β (TRIF), defense mechanism, innate
immunity, infection, natural killer cell
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INTRODUCTION
In the intestine, host defense mechanisms drive effector
immunity against pathogenic bacteria while regulating
inflammatory responses to normal flora. This selection of
host responses largely depends on pattern recognition receptors
(PRRs), the germ-line encoded receptors that detect molecular
components of microbial pathogens referred to as pathogen
associated molecular patterns (PAMPs). Upon recognition of
PAMPs, the cell is programmed to express a series of genes in
order to mount an appropriate immune response to fight off
the invading organism. Lipopolysaccharide (LPS), one of the
PAMPs of Gram-negative bacteria, exists abundantly in the
gastrointestinal lumen. Toll-like receptor 4 (TLR4) recognizes
LPS and transduces intracellular signaling pathways through the
adaptor molecules MyD88 or TRIF. Although TLR4 expression is
down-regulated in normal intestinal mucosa, the TRIF pathway
may have specific roles in intestinal homeostasis because its
activation is restricted to TLR4 and TLR3, while the MyD88
pathway is induced by all TLRs except for TLR3. On the other
hand, TLR3 exclusively induces the TRIF pathway in response to
dsRNA viruses and is abundantly expressed in intestinal mucosa
(Zarember and Godowski, 2002; Furrie et al., 2005; Monteleone
et al., 2008). Therefore, exogenous activation of TLR3 may
induce the TRIF-dependent host defense mechanism against
Gram-negative pathogens in the intestine.
TRIF is a toll/interleukin-1 receptor-like (TIR) domain-
containing adaptor protein that has been described to be a
strong inducer of type I IFNs. Upon activation, TRIF induces
activation of IRF3, NF-κB, and MAPK kinases resulting in
unique gene expression. Recently, we have shown that TRIF-
deficient (TrifLPS2) mice have impaired production of IFN-
γ by natural killer (NK) cells in the MLNs and defective
macrophage bactericidal function in response to enteric Yersinia
enterocolitica infection (Sotolongo et al., 2011). We have also
demonstrated that treatment of mice with synthetic dsRNA, poly
I:C (TLR3 ligand), reduced mortality during enteric infection
with Y. enterocolitica. These results suggest that TRIF could
be an innovative therapeutic target to boost host defense
against enteric pathogens. This effect of poly I:C also may be
clinically relevant as most enteric pathogens are Gram-negative
bacteria or viral pathogens that induce dsRNA during replication
in the cytosol. However, it is important to determine the
cellular and molecular mechanisms by which TRIF stimulation
confers host defense in the intestinal mucosal interface. In
addition, possible adverse effects of TRIF stimulation strategy
should be taken into account. Poly I:C has been extensively
studied as a potential immunologic adjuvant for viral infections,
cancer immunotherapies, and effective immunizations, but has
not been applied against bacterial infections (Verdijk et al.,
1999; Longhi et al., 2009; Seya and Matsumoto, 2009; Tewari
et al., 2010). Therefore, TRIF activation approach may have a
broad applicability to variety of pathogens (Matsumoto et al.,
2015).
The aim of this study is to dissect the underlying mechanism
by which poly I:C-mediated TRIF activation protects host
against enteric infection by Gram-negative pathogens. Systemic
administration of poly I:C leads to a unique defense mechanism
in the intestine that is mediated by mobilization of innate
immune cells to the MLN from intestinal mucosa and induction
of IFN-γ by NK cells in the MLN. This mobilization of innate
immune cells requires TLR4 mediated CCR7 expression on these
cells in the lamina propria and we show that systemic poly I:C
increased expression of TLR4 in ileal mucosa. The effects of poly
I:C are rapid and antigen non-specific and thus may be free from
drug resistance. Therefore, fortifying innate immune defense by
systemic activation of TRIF may be a reasonable strategy to fight
against enteric infection with bacterial pathogens.
MATERIALS AND METHODS
Mice and Procedures
WT C57BL/6J, TrifLPS2, and TLR4−/− mice were bred and
housed under specific pathogen-free conditions in the Cedars-
Sinai Medical Center animal facility. TLR3−/− mice were
purchased from the Jackson Laboratory. All protocols were
reviewed and approved by the Cedars-Sinai Institutional Animal
Care and Use Committee. Poly I:C was subcutaneously (SC)
injected (50µg/mouse; TOCRIS Bioscience, Bristol, UK) and
anti-IFNAR1 antibody (100µg i.p/mouse, Leinco Technologies,
St Lowis, MO) was administered at the same time. Flagellin
(10µg/mouse; Invivogen, San Diego, CA) and Pam3CSK4
(50µg/mouse; Invivogen, San Diego, CA) were injected SC.
Control mice received PBS. We used WT Y. enterocolitica (WA-
314 serotype O:8) and S. typhimurium (SL1344) in this study.
For infection studies, mice were orogastrically inoculated with
Y. enterocolitica (1 × 107 CFU/mouse) using a 22-gauge, round-
tipped feeding needle (Fine Science tools; Echeverry et al., 2007).
Cell Preparation and Purification
Single cell suspension of MLN was prepared by mechanical
disruption with 70µm nylon mesh. Peritoneal macrophages
were isolated from peritoneal lavage as described previously
(Sotolongo et al., 2011). WT NK (CD3-CD49+) and NKT
(CD3+CD49+) cells from the MLN were purified by magnetic
sorting with PE anti–mouse CD49 (DX5) and anti-PE Multi-
Sort kit (Miltenyi Biotec, San Diego, CA). Lamina propria cells
from small intestine were prepared as described previously
(Kanagavelu et al., 2014). Briefly, the intestine was cut into
small pieces and shaken at 200 r.p.m. for 20min at 37◦C with
Ca++ Mg++ free Hank’s balanced salt solution containing
5% fetal bovine serum (FBS) and 0.5M EDTA. The pieces
were further shaken at 200 r.p.m. for 60min at 37◦C with
RPMI1640 containing 5% FBS, collagenase VIII (30U/ml; Sigma,
St Lowis,MO) and trypsin inhibitor (0.24mg/ml; Sigma). Lamina
propria cells were collected by filtering through a 70µm cell
strainer and then were purified with lymphocyte-separation
medium (Cellgro, Corning, NY) by centrifugation at 800 g for
20min at 20◦C. LPS stimulation was carried out in a 96 well
plate for 12 h (10 ng/ml) with a cell density of 2 × 105/well.
CD11c+, F4/80+, and Gr-1hi cells were isolated by sorting using
FACSAria III. Cells were stimulated with poly I:C (10µg/ml)
for 12 h.
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MLN Bactericidal Assay
MLN cells from mice injected with poly I:C or control mice
were seeded with DME medium containing 10% FBS in a 96
well plate (2 × 105 cells/well). MLN cells were then infected
with Y. enterocolitica (MOI: 1) for 6 h at 37◦C in the presence
or absence of anti-IFNA1 antibody (10µg/ml). MLN cells
from control mice were treated with poly I:C (10µg/ml) with
or without anti-IFNA1 antibody (10µg/ml) for 30min then
infected with Y. enterocolitica (MOI: 1) for 6 h at 37◦C.MLN cells
were lysed with 300µl of distilled water and supernatants were
plated on Yersinia specific agar plates. The same procedure was
done for S. typhimurium (MOI: 10) infection in the presence of
gentamicin (10µg/ml). S. typhimurium associated with the MLN
cells were collected by lysing with 300µl of distilled water and
samples were plated on LB agar plates. Data were expressed as
fold changes over the results of the control samples.
Cell Staining and FACS Analysis
Surface staining of CD11c, F4/80, Gr-1, CCR7, CD3, CD4,
CD8, NK (CD3-CD49+), NKT (CD3+CD49+), B220, and
pDCs (CD11c+B220+) intracellular staining of phosphor-
STAT1 and STAT4, and IFN-γ were performed according to
the manufacturer’s instructions (eBioscience, San Diego, CA).
GolgiPlug (BD) was added to the last 1.5 h of incubation. Alexa
Fluor 488 conjugated anti-mouse γδTCR was purchased from
BioLegend (San Diego, CA). FACS analyses were performed on
an LSR II flow cytometer with FACS Diva (BD) and FlowJo
(Tree Star).
ELISA
NK cells were isolated from the MLN of WT mice as described
earlier. Peritoneal macrophages isolated from WT mice were
stimulated with poly I:C (10µg/ml) for 24 h and supernatants
were analyzed for IFN-β and IL-12p40 using ELISA duo kits
according to the manufacturer’s instructions (R&D Systems,
Minneapolis, MN). For the IFN-γ production from MLN cells,
MLN cells were isolated from mice 24 h post poly I:C injection
and incubated for 24 h in a 96 well plate (2.5 × 105/well). For
the in vitro macrophage NK cell co-culture assay, peritoneal
macrophages were pre-stimulated with poly I:C (10µg/ml) for
6 h, and freshly isolated splenic WT NK cells were co-cultured
for 24 h in the presence or absence of anti-IFNAR1 (10µg/ml)
or anti-IL-12 antibody (1µg/ml, Peprotech). Supernatants were
analyzed for IFN-γ using ELISA (R&D Systems).
Real-Time PCR
Total RNA was isolated from the small intestine using RNA Bee
(Tel-Test, Friendwood, TX) according to the manufacturer’s
instructions. A total of 1µg RNA was used as the template
for single-strand complementary DNA synthesis using the
QuantiTect Reverse Transcription Kit (Qiagen). Quantitative
real-time PCR was performed for TLR4 (Sense: CAGCAG
AGGAAGAACAAGAA and Antisense: TGCAAACAGACT
GGGTTTAG), IFN-β (Sense: GTCCTCAACTGCTCTCCACT,
and Antisense: GCAACCACCACTCATTCTG), IP-10 (Sense:
TCCCTCTCGCAAGGAC, and Antisense: TTGGCTAAAC
GCTTTCAT), IFN-γ (Sense: GCTTGTACCTTTACTTCACT
GAC, and Antisense: CTGGCCCGGAGTGTAGACAT), IL-18
(Sense: CCCAACGATAAAGAAGAACGCC and Antisense
TGTCTGTGCCTCCCGTGCTGGC), TNF-α (Sense: GGA
ATGAGAAGAGGCTGAGACAT and Antisense CGTGGA
ACTGGCAGAAGAGG), and β-actin (Sense: TACGACCAGA
GGCATACAG, and Antisense: ATGACCCAGATCATGTT
TGA). The complementary DNA was amplified using Maxima
SYBR Green/ROX (Thermo scientific, Pittsburgh, PA) on the
Lightcycler (Roche, Indianapolis, IN). The amplification results
of the genes of interest were normalized to the corresponding
β-actin results and analyzed using the delta-delta Ct method.
Statistical Analysis
Kaplan-Meier survival curve was generated for infectedmice, and
statistical differences were analyzed by Chi square test. Student’s
t-test was used for two independent groups of samples. One-
way ANOVA was used for more than two independent groups
of samples, followed by Tukey’s multiple comparison tests. All
tests were performed with GraphPad Prism (Version 5.0b), and a
P-value of <0.05 was considered statistically significant.
RESULTS
TLR3 is Required for Poly I:C Mediated
Protection of Mice from Y. enterocolitica
We have shown that SC injection of poly I:C confers mice
resistance to Y. enterocolitica infection through activation of
TRIF signaling (Sotolongo et al., 2011). In this study, we
sought to determine upstream mediators of TRIF signaling and
whether this protection is TRIF-specific or can be reproduced by
stimulation with other TLRs. Results demonstrated that systemic
administration of Pam3CSK4 (TLR2 ligand) or Flagellin (ligand
for TLR5 and NLRC4) did not result in improved survival
as was seen with poly I:C injection (Figure 1A). Protective
effect of poly I:C was not seen in TLR4−/− mice indicating an
indirect contribution of TLR4 signaling to poly I:C mediated
protection (Figure 1B). Of note, TLR4−/− mice received one-
fifth Y. enterocolitica dose of WT experiments (Figure 1A)
due to their higher susceptibility to the infection. Although
poly I:C may stimulate retinoic acid-inducible gene 1 (RIG-I)
and melanoma-differentiation associated gene 5 (MDA5) when
introduced into cytosol, poly I:C mediated protection against
Y. enterocolitica infection seems to be dependent on TLR3
mediated TRIF signaling as we could not observe the reduction
of Y. enterocolitica growth in theMLN by poly I:C injection when
we used TLR3−/− mice or TrifLPS2 mice (Figure 1C). We also
addressed whether SC dose of poly I:C had negative influence
in small intestinal mucosa because intraperitoneal injection of
poly I:C has been shown to induce dosage dependent mucosal
damage in the small intestine within 12 h (Zhou et al., 2007).
No histologically detectable mucosal damage was found up
to 800µg/mouse poly I:C by SC injection (Figure 1D). Taken
together, SC injection of poly I:C in a dose of 50µg confers
resistance to enteric Y. enterocolitica infection, which is mediated
through TLR3 dependent TRIF signaling without disruption of
intestinal mucosal integrity. Poly I:Cmediated protection of mice
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FIGURE 1 | Poly I:C protects mice from Y. enterocolitica infection, which depends on TLR3 and TLR4. (A) Survival of WT mice during oral Y. enterocolitica
infection (1× 107 CFU). Comparison of treatment among poly I:C, Fla and Pam3CSK4 (n = 10 each). (B) Survival of TLR4−/− mice during oral Y. enterocolitica
infection (0.2× 107 CFU) with or without poly I:C (n = 5 each). (C) Y. enterocolitica titers in the MLNs of TLR3−/− mice SC injected with or without poly I:C followed
by oral Y. enterocolitica infection (n = 6 each; day 7 post infection). Bottom graph shows Y. enterocolitica titers in the MLNs of TrifLPS2 mice 7 days post
Y. enterocolitica infection (0.2× 107 CFU) with or without poly I:C (n = 6 each). (D) Histological analysis of the small intestine taken from WT mice 24 h after SC
injection with poly I:C (800µg/mouse). *P < 0.05; NS, not significant. Error bars on graphs represent mean ± s.e.m.
from Y. enterocolitica infection also appear to involve TLR4
signaling.
Systemic Administration of Poly I:C
Mobilizes Innate Immune Cells from the
Lamina Propria to the MLN
To determine the underlying mechanisms of poly I:C-mediated
protection of mice against enteric Y. enterocolitica infection, we
examined alterations of cellular composition in the MLN 24 h
after poly I:C injection. FCM analysis of cellular composition
demonstrated an increased proportion of CD11c+, F4/80+, and
Gr-1hi cells in the MLN after poly I:C injection (Figure 2A).
These alterations of cellular composition were not observed in
TLR4−/− mice suggesting an involvement of TLR4 signaling
in the mobilization of these innate immune cells (Figure 2B).
Other cell types in the MLN did not show differences in
proportion after SC poly I:C injection (Figure S1). Majority of
mobilized DCs seemed to be myeloid DCs because increase
of plasmacytoid DCs in the MLN after poly I:C injection
was subtle (Figure 2A, Figure S1B). Because the MLN collects
intestinal lymphatics, we addressed whether these innate immune
cells were recruited from intestinal mucosa by detecting CCR7
expression in these cell types in the lamina propria (Figure 2C).
We confirmed upregulation of CCR7 expression in CD11c+,
F4/80+, and Gr-1hi cells in small intestinal lamia propria 24 h
after poly I:C injection (Figure 2C). Again, this upregulation
of CCR7 in these innate immune cells in the lamina propria
was not observed in TLR4−/− mice (Figure 2D). We confirmed
that mRNA expression of TLR4 in ileal mucosa was upregulated
after poly I:C injection (Figure 2E). In real time PCR analysis
of ileum samples, the upregulation of IFN-β, IFN-γ, and IP-10
mRNA expression was also observed (Figure 2E). Poly I:C may
induce IFN-γ through induction of IFN-β and IP-10 which in
turn may induce upregulation of TLR4 expression (Nguyen et al.,
2000; Tamai et al., 2003; Hold et al., 2011). This upregulation of
TLR4 seemed to be functional as LPS induced TNF-α expression
from lamina propria cells was significantly greater in poly I:C
treated mice compared to control mice (Figure 2F). Because
TLR4 signaling has been shown to induce CCR7 expression
(Schmid et al., 2011), these results suggest that systemic activation
of TLR3 mobilizes innate immune cells from lamina propria
to the MLN through TLR4 mediated upregulation of CCR7,
which may be associated with increased host resistance to enteric
bacteria infection.
Systemic Poly I:C Suppresses Growth of
Gram-Negative Bacteria in the MLN
Given that poly I:C mobilizes innate immune cells to traffic
into the MLN, we addressed whether these alterations in
innate immune cell populations contributed host resistance to
Y. enterocolitica infection. We found that MLN cells isolated 24 h
post poly I:C injection suppressed Y. enterocolitica growth 50%
more than MLN cells isolated from control mice (Figure 3A),
and that this growth suppressionwas abolished by intraperitoneal
administration of anti-IFNAR antibody together with SC poly I:C
(Figure 3A). The reduction of Y. enterocolitica by MLN cells of
poly I:C treated mice seems to be associated with TLR4-mediated
mobilization of innate immune cells because we did not see this
effect of poly I:C in TLR4−/− mice (Figure 3B). A similar effect
of poly I:C was observed on intracellular bacterial killing of the
MLN cells in a gentamicin protection assay using S. typhimurium
(Figure 3C). In addition, the mice that received anti-IFNAR
antibody did not show increased proportion of CD11c+, F4/80+,
and Gr-1hi cells in the MLN by poly I:C injection (Figure 3D).
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FIGURE 2 | Poly I:C mobilizes innate immune cells from lamina propria to MLN. (A,B) FCM analysis of CD11c+, F4/80+ and Gr-1hi cells in the MLN 24h after
poly I:C injection in WT or TLR4−/− mice (n = 3 each). (C,D) FCM analysis of CCR7 expression on CD11c+, F4/80+ and Gr-1hi cells in the MLNs 24 h after poly I:C
injection in WT or TLR4−/− mice (n = 3 each). (E) Real time PCR analysis of TLR4, IFN-β, IFN-γ, and IP-10 expression in the ileum of WT mice 24 h post poly I:C
injection (n = 10 each). (F) Real time PCR analysis of LPS induced TNF-α expression in lamina propria cells isolated from WT mice with or without poly I:C injection
(n = 4 mice each, LPS stimulation 10 ng/ml for 12 h). *P < 0.05; NS, not significant. Error bars on graphs represent mean ± s.e.m.
Therefore, systemic poly I:C leads to the mobilization of innate
immune cells in the MLN in type I IFN and TLR4 dependent
manner that facilitates elimination of bacteria in the MLN.
Poly I:C Suppresses Bacterial Growth in
the MLN through NK Cell Activation
Next we examined whether poly I:C also has direct effect
on bacterial elimination by MLN cells. When we examined
Y. enterocolitica growth in MLN cells, a significant reduction of
the number of Y. enterocolitica was observed in the presence of
poly I:C (Figure 4A). Unlike in vivo effect of poly I:C, however,
the direct effect of poly I:C on bacterial growth was independent
of TLR4 signaling as we saw the full effect of poly I:C on MLN
cells taken from TLR4−/− mice (Figure 4B).
Because IFN-γ is known to accelerate bacterial killing by
phagocytes and poly I:C may induce IFN-γ production in
variety of cells in vivo, we addressed whether poly I:C enhanced
IFN-γ production by MLN cells (Schroder et al., 2004; Jiang
et al., 2008). Supernatants of MLN cells that received poly
I:C during Y. enterocolitica infection demonstrated significantly
higher production of IFN-γ compared to supernatants of MLN
cells without poly I:C (Figure 4C). In addition, the expression
of IFN-β and IL-12 but not IL-18 mRNA was induced by poly
I:C stimulation in CD11c+, F4/80+, and Gr-1hi cells isolated
from the MLN suggesting underlying mechanism of enhanced
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FIGURE 3 | Gram-negative bacterial growth in the MLN is suppressed
by Poly I:C. (A,B) Y. enterocolitica killing assay in MLN cells (2× 105/well,
MOI: 1) taken from WT and TLR4−/− mice 24 h after poly I:C injection with or
without α-IFNAR antibody (n = 10 each). (C) Intracellular S. typhimurium killing
by the MLN cells (2× 105/well, MOI: 20) using gentamicin protection assay.
The MLN cells were obtained from WT mice 24 h after poly I:C injection with or
without α-IFNAR antibody (n = 10 each). (D) FCM analysis of CD11c+,
F4/80+, and Gr-1hi cells in the MLN taken from WT mice 24 h after poly I:C
injection with or without α-IFNAR antibody (n = 4 each). *P < 0.05; NS, not
significant. Error bars on graphs represent mean ± s.e.m.
IFN-γ production by MLN cells (Figure 4D). Blocking IL-12 and
IFN-γ during Y. enterocolitica infection in MLN cells actually
showed significant reduction of bactericidal activity of MLN cells
(Figure 4E). Blocking IFNAR had modest effect on bactericidal
activity of MLN cells; differences were found neither between
MLN cells nor MLN cells with poly I:C. The partial effect of
IFNAR blockade may be due to the cell type difference in
responses to type I IFNs.
Based on our finding that NK cell is important as a major
source of IFN-γ for optimal elimination of Gram-negative
bacteria in the MLN (Sotolongo et al., 2011), we tested bacterial
growth in MLN cells after depletion of NK cells. Although we
still found substantial growth suppression of Y. enterocolitica by
poly I:C without NK cells, its effect was significantly lowered by
depletion of NK cells (Figure 4F). These results indicate that poly
I:C may directly facilitate bacterial killing in the MLN through
induction of IL-12 and IFNs and activation of NK cells.
Macrophages Induce IFN-γ Expression
from NK Cells through Expression of Type I
IFNs and IL-12
In order to determine how poly I:C activates NK cells, next we
examined the mechanism of IFN-γ induction in NK cells that is
mediated by poly I:C stimulated innate immune cells. We have
shown an important role of IFN-β induced by macrophages in
NK cell production of IFN-γ (Sotolongo et al., 2011). First we
confirmed the contribution of type I IFNs and IL-12 to IFN-
γ expression by NK cells in our system by FCM. Substantial
reduction of IFN-γ expression from NK cells was observed
during in vitro Y. enterocolitica infection of MLN cells when
IFNAR or IL-12 were blocked (Figure 5A). In order to further
address whether these cytokines expressed by poly I:C-stimulated
macrophages are actually involved in IFN-γ expression from
NK cells and if so what was the extent of the effect of each
cytokine, we utilized mouse peritoneal macrophages based on
their good response to poly I:C to induce protein production
of IFN-β and IL-12 (Figure 5B). In addition to what we found
earlier (Sotolongo et al., 2011), IFN-γ induction from NK cells
was significantly suppressed by blockade of not only type I IFNs
but also of IL-12 while the degree of suppression was greater
in blockade of type I IFNs (Figures 5C,D). On the other hand,
direct stimulation of NK cells with poly I:C did not induce IFN-
γ expression (Figure 5E). These results indicate that poly I:C
mediated activation of NK cells in the MLN is mediated by both
type I IFNs and IL-12 that can be secreted from innate immune
cells such as CD11c+, F4/80+, and Gr-1hi cells.
Poly I:C Injection Selectively Enhances
Activation of STAT1 and STAT4 in NK Cells
in the MLN during Y. enterocolitica
Infection
Given both type I IFNs and IL-12 signaling are involved in NK
cell induction of IFN-γ by poly I:C-stimulated macrophages,
we examined how the IFN-γ induction in NK cells is
transcriptionally regulated by analyzing phosphorylation of
STAT1 and STAT4. Blocking type I IFNs as well as IL-12 during
co-culture with poly I:C stimulated macrophages both reduced
STAT1 phosphorylation in NK cells (Figure 6A). However,
phosphorylation of STAT4 was relatively weak and only a
modest suppression was seen by blocking type I IFNs or IL-12
(Figure 6B). As we have demonstrated that NK cells are major
cell type expressing IFN-γ in the MLN during Y. enterocolitica
infection, next we addressed whether poly I:C enhanced the
phosphorylation of STAT1 and STAT4 in NK cells in the
MLN during Y. enterocolitica infection. We found significantly
increased phosphorylation of STAT1 and STAT4 in NK cells
by poly I:C administration (Figures 6C,D). Slightly increased
phosphorylation in both STAT1 and STAT4 was found in T cells
but NKT cells demonstrated only minimally increased STAT4
phosphorylation by poly I:C administration (Figures 6C,D).
These results suggest that NK cells are a dominant cell type that
express IFN-γ in response to poly I:C in the MLN during enteric
Y. enterocolitica infection, which requires activation of STAT1
and, to a lesser extent, STAT4.
DISCUSSION
The combined effects of globalization of the food supply
and human travel have increased risks of enteropathogenic
bacterial infections. Although antibiotic therapy may, in
principle, be effective, the acquisition of antibiotic resistance
to enteropathogens has become a serious clinical and public
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FIGURE 4 | Direct suppression of bacterial growth in the MLN by poly I:C requires NK cells. (A,B) In vitro Y. enterocolitica killing assay using WT or TLR4−/−
MLN cells in the presence or absence of poly I:C (n = 10 each). (C) ELISA analysis of IFN-γ production from MLN cells isolated from mice with or without poly I:C
treatment (n = 4 mice each). (D) Real time PCR analysis of IFN-β, IL-12, and IL-18 expression from different innate immune cells of the MLN in response to poly I:C
(n = 4 mice each, data from triplicated samples). (E) In vitro infection of MLN cells with Y. enterocolitica in the presence or absence of poly I:C together with
neutralizing antibodies against IL-12, IFNAR, and IFN-γ (n = 6 each). (F) In vitro Y. enterocolitica killing assay in WT MLN cells that were depleted of NK cells. The
effect of poly I:C in the presence or absence of α-IFNAR antibody (n = 10 each). *P < 0.05; NS, not significant. Error bars on graphs represent mean ± s.e.m.
health concern (White et al., 2002; Walsh and Fanning, 2008).
In the face of these issues, alternative strategies for preventing
and treating such outbreaks are urgently needed. The severity
of infections depends on proliferation of pathogens and the
host immune responses, therefore, suppression of initial growth
of pathogens by induction of a rapid immune response is
crucial. In this regard, exploring innate immune signaling
and regulation of protective immunity in the intestine is
particularly significant. We have targeted TRIF signaling as a
novel approach to tackle enteropathogenic infections based on
our previous report that TRIF-deficient mice are susceptible
to enteric infection with Gram-negative bacteria (Sotolongo
et al., 2011). In the current study, we demonstrated the
mechanisms by which systemic poly I:C administration facilitates
elimination of infected Gram-negative enteropathogens in the
MLN; poly I:C rearranged intestinal innate immune cells in
the MLN by directly activating IFN signaling and indirectly
through mobilization of innate immune cells from intestinal
mucosa. Pathogens are less likely to induce resistance to
this strategy because TRIF gene has been well conserved
throughout the evolution and has not been overcome by any
microorganisms.
Utilization of TLR signaling as a means to fortify host
defense against pathogenic infections has been attempted. For
example, exogenous stimulation of TLR5 and TLR9 has been
assessed in mouse models of enteric Salmonella and vaginal
Herpes simplex infections, respectively (Mariotti et al., 2002;
Shen and Iwasaki, 2006; Vijay-Kumar et al., 2008). However,
these efforts have been only partially successful because most
TLR agonists produce strong adverse effects mainly induced by
MyD88-dependent pro-inflammatory cytokines, and have not
been approved for human use (Mata-Haro et al., 2007; O’Neill
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FIGURE 5 | Expression of type I IFNs and IL-12p40 by macrophages induces IFN-γ expression in NK cells. (A) FCM analysis of IFN-γ expression from NK
cells in the MLN; MLN cells were isolated from mice that received poly I:C and infected with Y. enterocolitica for 6 h (MOI: 1). (B) ELISA measurement of IFN-γ and
IL-12p40 production from WT peritoneal macrophages stimulated with poly I:C for 24 h (n = 10 each). (C,D) Peritoneal macrophages from WT mice were stimulated
with poly I:C for 6 h in the presence or absence of α-IFNAR or α-IL-12 antibodies. After washing out poly I:C, macrophages were co-cultured with WT splenic NK cells
for 24 h and IFN-γ production was measured using ELISA (n = 10 each). (E) ELISA measurement of IFN-γ production by NK cells stimulated with poly I:C for 24 h
(n = 10 each). *P < 0.05; NS, not significant. Error bars on graphs represent mean ± s.e.m.
et al., 2009). In addition, the effect of TLR5 ligand on enteric
bacterial infections might depend on the type of flagellin used
as the previous report used Salmonella flagellin to fight against
Salmonella infection (Vijay-Kumar et al., 2008) and we did
not see the protective effect of flagellin on a different bacterial
pathogen, Y. enterocolitica. By contrast, our results show that
the TLR3 stimulation strategy is effective on multiple Gram-
negative enteropathogens. TLR3 also has been shown to confer
a defense against enteric protozoan infection (Lantier et al.,
2014). TLR3-mediated TRIF signaling is unique in that it induces
a distinct signaling pathway that mainly induces type I IFNs.
The activation of this signaling by poly I:C has proven to be a
potent adjuvant for immunotherapy against viruses, parasites,
and cancers (Verdijk et al., 1999; Longhi et al., 2009; Seya and
Matsumoto, 2009; Tewari et al., 2010). Therefore, in addition to
boosting host innate defense mechanisms, the TRIF stimulation
strategy may have universal applicability to enteric infection with
many pathogens.
There are conflicting results in terms of the protective effect
of poly I:C on the animal models of lung infections (Pyles
et al., 2010; Tian et al., 2012). Intranasal administration of poly
I:C enhanced bacterial clearance and extended survival in a
mouse model of Gram-negative F. tularensis infection in the
lungs (Pyles et al., 2010). On the other hand, pre-treatment with
poly I:C resulted in impaired pulmonary clearance of secondary
bacterial infections, particularly of Gram-positive Methicillin-
resistant Staphylococcus aureus and Streptococcus pneumoniae
(Tian et al., 2012). Therefore, the protective effect of poly I:C in
infectious diseases may be restricted either to the gastrointestinal
infections or Gram-negative bacterial infections in the case of
other organs.
One of the mechanisms by which systemic administration of
poly I:C induced protection against enteric bacterial infection was
mobilization of innate immune cells in the MLN from intestinal
mucosa. Thismobilization was dependent on type I IFN signaling
and TLR4-mediated CCR7 expression in these innate immune
cells and was associated with mucosal expression of IFN-γ. Since
TLR4 ligand LPS is abundantly available in intestinal lumen and
poly I:C upregulated mucosal expression of TLR4, it is reasonable
to think that systemic poly I:C increased sensitivity of TLR4
in intestinal mucosa. We showed increased TNF-α expression
by lamina propria cells of the mice that received poly I:C in
response to LPS. This is supported by the fact that poly I:C
induced mucosal expression of IFN-γ as TLR4 sensitivity can be
upregulated by IFN-γ (Abreu et al., 2002; Suzuki et al., 2003). The
other mechanism involves expression of IFN-γ from activated
NK cells in the MLN. We and others have demonstrated the
requirement of antigen presenting cells in this activation of NK
cells (Akazawa et al., 2007; Sotolongo et al., 2011). Our data
further showed that both STAT1 and STAT4 activation in NK
cells are involved in the induction of IFN-γ in NK cells. It is likely
that multiple types of innate immune cells are involved in host
defense mechanism against Gram-negative enteropathogens and
their roles differ based on the location (Autenrieth et al., 2012;
Sugiura et al., 2013). For example, lamina propria DCs might
play an important role to establish adaptive immunity against
locally invasive pathogens such as Salmonella enterica under
the tight regulation with retinoic acid and TGF-β (Uematsu
et al., 2008). Limitation of our study is that we used peritoneal
macrophages to examine underlying mechanism of activation
and IFN-γ secretion of NK cells in the MLN. Although we found
significant increase of bactericidal activity in lamina propria cells
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FIGURE 6 | Poly I:C activates STAT1 and STAT4 in NK cells in the MLN upon Y. enterocolitica infection. (A,B) FCM analysis of phosphorylation of STAT1 and
STAT4 in WT NK cells co-cultured with WT peritoneal macrophages 24 h after stimulation with poly I:C in the presence or absence of α-IFNAR or α-IL-12 antibody
(n = 10 each). (C,D) FCM analysis of phosphorylation of STAT1 and STAT4 in NK, NKT, and T cells from the MLN obtained from WT mice 48 h after oral
Y. enterocolitica infection (n = 4 each). The effect of poly I:C is shown. *P < 0.05; NS, not significant. Error bars on graphs represent mean ± s.e.m.
isolated 24 h post poly I:C injection of mice (5.7 ± 0.1 poly I:C
treated mice vs. 5.5 ± 0.1 non-treated mice, Log10CFU/2 × 10
5
cells; MOI= 1 infected in 96 well plate for 6 h), the role of lamina
propria cells in host defense against Y. enterocolitica infection
has been obscure (Oellerich et al., 2007). Further research will
help identify the effect of systemic poly I:C on lamina propria as
well as splenic cells during enteric infection with Gram-negative
bacterial pathogens.
In summary, our results demonstrated that subcutaneous
administration of poly I:C induced protective immunity against
enteric bacterial infection. This protective immunity was
mediated at least in part by an innate immune interaction
between intestinal mucosa and the MLN through sequential
activations of TLR3 and TLR4 signaling that were linked by
type I IFN signaling. This defense mechanism can be utilized
to defend against multiple bacterial enteropathogens as it is
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mediated by antigen-nonspecific immunity and thus will not
elicit drug resistance.
AUTHOR CONTRIBUTIONS
JR performed in vitro infection FCM analysis and ELISA
assays, and drafted manuscript, SK performed FCM
analysis, real-time PCR, in vivo infection, and helped
manuscript drafting, CF helped in vitro infection, FCM
analysis, and real-time PCR analysis, LR maintained mouse
colonies and performed RNA preparation, RR performed
RNA preparation, helped in vitro infection and bacterial
preparation, DS designed experiments and analyzed
FCM data, MF designed experiments, performed in vitro
infection and FCM analysis, executed all experiments, wrote
manuscript.
ACKNOWLEDGMENTS
This study was supported by NIH grant AI095255 for MF and
DK093578 for DS. We thank Loren C. Karp for the review of the
manuscript.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fcimb.
2015.00105
Figure S1 | Poly I:C does not mobilize other immune cells from lamina
propria to the MLN. (A) FCM analysis of CD3, CD4, CD8, NK, NKT, and B220
cells in the MLN 24h after poly I:C injection in WT mice (n = 3 each). (B) FCM
analysis of pDCs (CD11c+B220+), γδT cells in the MLN 24h after poly I:C
injection in WT mice (Left graph, n = 3 each) and TLR4−/− mice (Right graph,
n = 3 each). NS, not significant. Error bars on graphs represent mean ± s.e.m.
REFERENCES
Abreu, M. T., Arnold, E. T., Thomas, L. S., Gonsky, R., Zhou, Y., Hu, B., et al.
(2002). TLR4 and MD-2 expression is regulated by immune-mediated signals
in human intestinal epithelial cells. J. Biol. Chem. 277, 20431–20437. doi:
10.1074/jbc.M110333200
Akazawa, T., Ebihara, T., Okuno, M., Okuda, Y., Shingai, M., Tsujimura, K., et al.
(2007). Antitumor NK activation induced by the Toll-like receptor 3-TICAM-
1 (TRIF) pathway in myeloid dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 104,
252–257. doi: 10.1073/pnas.0605978104
Autenrieth, S. E., Warnke, P., Wabnitz, G. H., Lucero Estrada, C., Pasquevich, K.
A., Drechsler, D., et al. (2012). Depletion of dendritic cells enhances innate
anti-bacterial host defense throughmodulation of phagocyte homeostasis. PLoS
Pathog. 8:e1002552. doi: 10.1371/journal.ppat.1002552
Echeverry, A., Schesser, K., and Adkins, B. (2007). Murine neonates are highly
resistant to Yersinia enterocolitica following orogastric exposure. Infect.
Immun. 75, 2234–2243. doi: 10.1128/IAI.01681-06
Furrie, E., MacFarlane, S., Thomson, G., and MacFarlane, G. T. (2005). Toll-
like receptors-2, -3 and -4 expression patterns on human colon and their
regulation by mucosal-associated bacteria. Immunology 115, 565–574. doi:
10.1111/j.1365-2567.2005.02200.x
Hold, G. L., Mukhopadhya, I., and Monie, T. P. (2011). Innate immune sensors
and gastrointestinal bacterial infections. Clin. Dev. Immunol. 2011:579650. doi:
10.1155/2011/579650
Jiang, Q., Wei, H., and Tian, Z. (2008). IFN-producing killer dendritic cells
contribute to the inhibitory effect of poly I:C on the progression of murine
melanoma. J. Immunother. 31, 555–562. doi: 10.1097/CJI.0b013e31817d8e75
Kanagavelu, S., Flores, C., Termini, J. M., Riveron, R., Romero, L., Chung, K.,
et al. (2014). TIR-domain-containing adapter-inducing interferon-beta (TRIF)
regulates Th17-mediated intestinal immunopathology in colitis. Mucosal
Immunol. 2, 296–306. doi: 10.1038/mi.2014.67
Lantier, L., Drouet, F., Guesdon, W., Mancassola, R., Metton, C., Lo-Man, R.,
et al. (2014). Poly(I:C)-induced protection of neonatal mice against intestinal
Cryptosporidium parvum infection requires an additional TLR5 signal
provided by the gut flora. J. Infect. Dis. 209, 457–467. doi: 10.1093/infdis/jit432
Longhi, M. P., Trumpfheller, C., Idoyaga, J., Caskey, M., Matos, I., Kluger, C., et al.
(2009). Dendritic cells require a systemic type I interferon response to mature
and induce CD4+ Th1 immunity with poly IC as adjuvant. J. Exp. Med. 206,
1589–1602. doi: 10.1084/jem.20090247
Mariotti, S., Teloni, R., von Hunolstein, C., Romagnoli, G., Orefici, G., and
Nisini, R. (2002). Immunogenicity of anti-Haemophilus influenzae type b
CRM197 conjugate following mucosal vaccination with oligodeoxynucleotide
containing immunostimulatory sequences as adjuvant. Vaccine 20, 2229–2239.
doi: 10.1016/S0264-410X(02)00113-5
Mata-Haro, V., Cekic, C., Martin, M., Chilton, P. M., Casella, C. R., and Mitchell,
T. C. (2007). The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased
agonist of TLR4. Science 316, 1628–1632. doi: 10.1126/science.1138963
Matsumoto, M., Tatematsu, M., Nishikawa, F., Azuma, M., Ishii, N., Morii-Sakai,
A., et al. (2015). Defined TLR3-specific adjuvant that induces NK and CTL
activation without significant cytokine production in vivo. Nat. Commun. 6,
6280. doi: 10.1038/ncomms7280
Monteleone, I., Platt, A. M., Jaensson, E., Agace, W. W., and Mowat, A. M.
(2008). IL-10-dependent partial refractoriness to Toll-like receptor stimulation
modulates gut mucosal dendritic cell function. Eur. J. Immunol. 38, 1533–1547.
doi: 10.1002/eji.200737909
Nguyen, K. B., Cousens, L. P., Doughty, L. A., Pien, G. C., Durbin, J. E., and
Biron, C. A. (2000). Interferon alpha/beta-mediated inhibition and promotion
of interferon gamma: STAT1 resolves a paradox. Nat. Immunol. 1, 70–76. doi:
10.1038/76940
Oellerich, M. F., Jacobi, C. A., Freund, S., Niedung, K., Bach, A., Heesemann, J.,
et al. (2007). Yersinia enterocolitica infection of mice reveals clonal invasion
and abscess formation. Infect. Immun. 75, 3802–3811. doi: 10.1128/IAI.00
419-07
O’Neill, L. A., Bryant, C. E., and Doyle, S. L. (2009). Therapeutic targeting of Toll-
like receptors for infectious and inflammatory diseases and cancer. Pharmacol.
Rev. 61, 177–197. doi: 10.1124/pr.109.001073
Pyles, R. B., Jezek, G. E., and Eaves-Pyles, T. D. (2010). Toll-like receptor 3
agonist protection against experimental Francisella tularensis respiratory tract
infection. Infect. Immun. 78, 1700–1710. doi: 10.1128/IAI.00736-09
Schmid, M. A., Takizawa, H., Baumjohann, D. R., Saito, Y., and Manz, M. G.
(2011). Bone marrow dendritic cell progenitors sense pathogens via Toll-
like receptors and subsequently migrate to inflamed lymph nodes. Blood 118,
4829–4840. doi: 10.1182/blood-2011-03-344960
Schroder, K., Hertzog, P. J., Ravasi, T., andHume, D. A. (2004). Interferon-gamma:
an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75, 163–189.
doi: 10.1189/jlb.0603252
Seya, T., and Matsumoto, M. (2009). The extrinsic RNA-sensing pathway
for adjuvant immunotherapy of cancer. Cancer Immunol. Immunother. 58,
1175–1184. doi: 10.1007/s00262-008-0652-9
Shen, H., and Iwasaki, A. (2006). A crucial role for plasmacytoid dendritic cells
in antiviral protection by CpG ODN-based vaginal microbicide. J. Clin. Invest.
116, 2237–2243. doi: 10.1172/JCI28681
Sotolongo, J., España, C., Echeverry, A., Siefker, D., Altman, N., Zaias, J., et al.
(2011). Host innate recognition of an intestinal bacterial pathogen induces
TRIF-dependent protective immunity. J. Exp. Med. 208, 2705–2716. doi:
10.1084/jem.20110547
Sugiura, Y., Kamdar, K., Khakpour, S., Young, G., Karpus, W. J., and DePaolo,
R. W. (2013). TLR1-induced chemokine production is critical for mucosal
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 10 January 2016 | Volume 5 | Article 105
Ruiz et al. TRIF Defenses against Bacterial Enteropathogens
immunity against Yersinia enterocolitica.Mucosal Immunol. 6, 1101–1109. doi:
10.1038/mi.2013.5
Suzuki, M., Hisamatsu, T., and Podolsky, D. K. (2003). Gamma interferon
augments the intracellular pathway for lipopolysaccharide (LPS) recognition
in human intestinal epithelial cells through coordinated up-regulation of LPS
uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex.
Infect. Immun. 71, 3503–3511. doi: 10.1128/IAI.71.6.3503-3511.2003
Tamai, R., Sugawara, S., Takeuchi, O., Akira, S., and Takada, H. (2003). Synergistic
effects of lipopolysaccharide and interferon-gamma in inducing interleukin-8
production in human monocytic THP-1 cells is accompanied by up-regulation
of CD14, Toll-like receptor 4, MD-2 and MyD88 expression. J. Endotoxin Res.
9, 145–153. doi: 10.1179/096805103125001540
Tewari, K., Flynn, B. J., Boscardin, S. B., Kastenmueller, K., Salazar, A. M.,
Anderson, C. A., et al. (2010). Poly(I:C) is an effective adjuvant for antibody
and multi-functional CD4+ T cell responses to Plasmodium falciparum
circumsporozoite protein (CSP) and alphaDEC-CSP in non human primates.
Vaccine 28, 7256–7266. doi: 10.1016/j.vaccine.2010.08.098
Tian, X., Xu, F., Lung, W. Y., Meyerson, C., Ghaffari, A. A., Cheng, G., et al.
(2012). Poly I:C enhances susceptibility to secondary pulmonary infections
by gram-positive bacteria. PLoS ONE 7:e41879. doi: 10.1371/journal.pone.00
41879
Uematsu, S., Fujimoto, K., Jang, M. H., Yang, B. G., Jung, Y. J., Nishiyama, M., et al.
(2008). Regulation of humoral and cellular gut immunity by lamina propria
dendritic cells expressing Toll-like receptor 5. Nat. Immunol. 9, 769–776. doi:
10.1038/ni.1622
Verdijk, R. M., Mutis, T., Esendam, B., Kamp, J., Melief, C. J., Brand, A.,
et al. (1999). Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces
stable maturation of functionally active human dendritic cells. J. Immunol.
163, 57–61.
Vijay-Kumar, M., Aitken, J. D., Sanders, C. J., Frias, A., Sloane, V. M., Xu, J., et al.
(2008). Flagellin treatment protects against chemicals, bacteria, viruses, and
radiation. J. Immunol. 180, 8280–8285. doi: 10.4049/jimmunol.180.12.8280
Walsh, C., and Fanning, S. (2008). Antimicrobial resistance in foodborne
pathogens–a cause for concern? Curr. Drug Targets 9, 808–815. doi:
10.2174/138945008785747761
White, D. G., Zhao, S., Simjee, S., Wagner, D. D., and McDermott, P. F. (2002).
Antimicrobial resistance of foodborne pathogens. Microbes Infect. 4, 405–412.
doi: 10.1016/S1286-4579(02)01554-X
Zarember, K. A., and Godowski, P. J. (2002). Tissue expression of human Toll-like
receptors and differential regulation of Toll-like receptor mRNAs in leukocytes
in response to microbes, their products, and cytokines. J. Immunol. 168,
554–561. doi: 10.4049/jimmunol.168.2.554
Zhou, R., Wei, H., Sun, R., Zhang, J., and Tian, Z. (2007). NKG2D recognition
mediates Toll-like receptor 3 signaling-induced breakdown of epithelial
homeostasis in the small intestines of mice. Proc. Natl. Acad. Sci. U.S.A. 104,
7512–7515. doi: 10.1073/pnas.0700822104
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2016 Ruiz, Kanagavelu, Flores, Romero, Riveron, Shih and Fukata.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 11 January 2016 | Volume 5 | Article 105
